A comparison of tau and 14-3-3 protein in the diagnosis of Creutzfeldt-Jakob disease

DOI Web Site 2 Citations
  • Clive Hamlin
    From the Departments of Pathology (National Prion Disease Pathology Surveillance Center) (C.H., G.P., S.B., E.S., C.H., M.C., C.S.) and Epidemiology and Biostatistics (S.D., D.Y.R.), Case Western Reserve University, Cleveland, OH; and Istituto Neurologico Carlo Besta (A.B.), Milan, Italy.
  • Gianfranco Puoti
    From the Departments of Pathology (National Prion Disease Pathology Surveillance Center) (C.H., G.P., S.B., E.S., C.H., M.C., C.S.) and Epidemiology and Biostatistics (S.D., D.Y.R.), Case Western Reserve University, Cleveland, OH; and Istituto Neurologico Carlo Besta (A.B.), Milan, Italy.
  • Sally Berri
    From the Departments of Pathology (National Prion Disease Pathology Surveillance Center) (C.H., G.P., S.B., E.S., C.H., M.C., C.S.) and Epidemiology and Biostatistics (S.D., D.Y.R.), Case Western Reserve University, Cleveland, OH; and Istituto Neurologico Carlo Besta (A.B.), Milan, Italy.
  • Elliott Sting
    From the Departments of Pathology (National Prion Disease Pathology Surveillance Center) (C.H., G.P., S.B., E.S., C.H., M.C., C.S.) and Epidemiology and Biostatistics (S.D., D.Y.R.), Case Western Reserve University, Cleveland, OH; and Istituto Neurologico Carlo Besta (A.B.), Milan, Italy.
  • Carrie Harris
    From the Departments of Pathology (National Prion Disease Pathology Surveillance Center) (C.H., G.P., S.B., E.S., C.H., M.C., C.S.) and Epidemiology and Biostatistics (S.D., D.Y.R.), Case Western Reserve University, Cleveland, OH; and Istituto Neurologico Carlo Besta (A.B.), Milan, Italy.
  • Mark Cohen
    From the Departments of Pathology (National Prion Disease Pathology Surveillance Center) (C.H., G.P., S.B., E.S., C.H., M.C., C.S.) and Epidemiology and Biostatistics (S.D., D.Y.R.), Case Western Reserve University, Cleveland, OH; and Istituto Neurologico Carlo Besta (A.B.), Milan, Italy.
  • Charles Spear
    From the Departments of Pathology (National Prion Disease Pathology Surveillance Center) (C.H., G.P., S.B., E.S., C.H., M.C., C.S.) and Epidemiology and Biostatistics (S.D., D.Y.R.), Case Western Reserve University, Cleveland, OH; and Istituto Neurologico Carlo Besta (A.B.), Milan, Italy.
  • Alberto Bizzi
    From the Departments of Pathology (National Prion Disease Pathology Surveillance Center) (C.H., G.P., S.B., E.S., C.H., M.C., C.S.) and Epidemiology and Biostatistics (S.D., D.Y.R.), Case Western Reserve University, Cleveland, OH; and Istituto Neurologico Carlo Besta (A.B.), Milan, Italy.
  • Sara M. Debanne
    From the Departments of Pathology (National Prion Disease Pathology Surveillance Center) (C.H., G.P., S.B., E.S., C.H., M.C., C.S.) and Epidemiology and Biostatistics (S.D., D.Y.R.), Case Western Reserve University, Cleveland, OH; and Istituto Neurologico Carlo Besta (A.B.), Milan, Italy.
  • Douglas Y. Rowland
    From the Departments of Pathology (National Prion Disease Pathology Surveillance Center) (C.H., G.P., S.B., E.S., C.H., M.C., C.S.) and Epidemiology and Biostatistics (S.D., D.Y.R.), Case Western Reserve University, Cleveland, OH; and Istituto Neurologico Carlo Besta (A.B.), Milan, Italy.

Journal

  • Neurology

    Neurology 79 (6), 547-552, 2012-08-07

    Ovid Technologies (Wolters Kluwer Health)

Citations (2)*help

See more

Details 詳細情報について

Report a problem

Back to top